Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.
Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma.
复制标题
DOI:
10.1002/ijc.29496
复制
发表时间:
2015-09-15
影响因子:
6.4
通讯作者:
Sinicrope, Frank A.
中科院分区:
文献类型:
--
作者:
Zaanan, Aziz;Park, Jae Myung;Tougeron, David;Huang, Shengbing;Wu, Tsung-Teh;Foster, Nathan R.;Sinicrope, Frank A.
Beclin 1 is an essential regulator of autophagy that is induced in response to cellular stress and serves to maintain cell survival in established tumors. We recently demonstrated that Beclin 1 suppression can sensitize colorectal cancer cells to radiation-induced DNA damage and apoptosis. Therefore, we hypothesized that the level of Beclin 1 expression may be associated with radiation sensitivity in vivo. We determined the association of Beclin 1 expression in pre-treatment rectal cancer tissues with response to neoadjuvant chemoradiation in surgical resection specimens. Consecutive stage II and III (n=96) rectal adenocarcinoma patients were treated with neoadjuvant chemoradiation followed by surgical resection with curative intent. Beclin 1 was analyzed by immunohistochemistry and the expression level was dichotomized at the median value with categorization into low and high groups. We identified 56 (58.3%) and 40 (41.7%) patients with high vs low level Beclin 1 expression, respectively. Patients with high vs low Beclin 1 expression were significantly less likely to be downstaged after chemoradiation treatment [45% (25/55) vs 58% (22/38); p=0.02]. In a multivariable analysis adjusted for age, sex, histological grade and baseline TNM stage, the impact of Beclin 1 expression on tumor downstaging remained statistically significant (p=0.03). The association of the level of Beclin 1 expression with the rate of tumor downstaging after chemoradiation is consistent with in vitro data, and suggests that Beclin 1 may be a predictive biomarker for the efficacy of chemoradiation in rectal cancer patients.
登录
查看更多内容
影响因子:
168.9
作者:
Sebag-Montefiore, David;Stephens, Richard J.;Steele, Robert;Monson, John;Grieve, Robert;Khanna, Subhash;Quirke, Phil;Couture, Jean;de Metz, Catherine;Myint, Arthur Sun;Bessell, Eric;Griffiths, Gareth;Thompson, Lindsay C.;Parmar, Mahesh
通讯作者:
Parmar, Mahesh
影响因子:
4.6
作者:
Sui X;Kong N;Wang X;Fang Y;Hu X;Xu Y;Chen W;Wang K;Li D;Jin W;Lou F;Zheng Y;Hu H;Gong L;Zhou X;Pan H;Han W
通讯作者:
Han W
影响因子:
8.4
作者:
Li, Jie;Hou, Ni;Kuwano, Hiroyuki
通讯作者:
Kuwano, Hiroyuki
影响因子:
158.5
作者:
Sauer, R;Becker, H;Raab, R
通讯作者:
Raab, R
DOI:
10.1097/00000421-200104000-00001
发表时间:
2001-04-01
影响因子:
2.6
作者:
Janjan, NA;Crane, C;Skibber, J
通讯作者:
Skibber, J